MedTrace Logo

Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients

NCT06915961 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-04-08

No results posted yet for this study

Summary

To implement a quality improvement plan aimed at achieving a 5% increase in the Forced expiratory volume in 1st second (FEV1) (% predicted value) in cystic fibrosis (CF) patients with impaired pulmonary function parameters over 12 months. Additionally, the plan aims to measure serum human epididymis protein 4 (HE4) levels in the studied subjects before and after pulmonary function improvement.

Conditions

  • Cystic Fibrosis (CF)

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Eman Fawzy · Ain Shams University

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-07
Primary Completion
2025-10-07
Completion
2025-12-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06915961 on ClinicalTrials.gov